An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer
Clinical trial NCT01006356 · COMPLETED
Trial details
- NCT number
- NCT01006356
- Sponsor
- Janssen Korea, Ltd., Korea
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2009-08-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.